Dr. Horton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
89 French St
New Brunswick, NJ 08901Phone+1 732-235-4980Fax+1 732-235-5002
Summary
- Daniel B. Horton, MD, MSCE is a pediatric rheumatologist based in New Brunswick, NJ. He completed his medical education at Harvard Medical School in 2008, followed by a Pediatrics Residency at the Children's Hospital of Philadelphia and a Pediatric Rheumatology Fellowship at Nemours Children's Health in Wilmington, Delaware. Dr. Horton performs research in a variety of areas, including research on juvenile idiopathic arthritis, pediatric medication use and safety, child health, team science, and COVID-19.
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/Nemours Children's Health, WilmingtonFellowship, Pediatric Rheumatology, 2011 - 2014
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 2008 - 2011
- Harvard Medical SchoolClass of 2008
Certifications & Licensure
- NJ State Medical License 2016 - 2025
- DE State Medical License 2011 - 2017
- PA State Medical License 2008 - 2013
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Rheumatology
Publications & Presentations
PubMed
- Pediatric Pharmacoepidemiology and Drug Development From a Regulatory Perspective.Ann W McMahon, Daniel B Horton, Yeruk Mulugeta, Lynne Yao
Clinical Pharmacology and Therapeutics. 2025-02-18 - Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task force.Veronika Rypdal, Hermine I Brunner, Brian M Feldman, Nicolino Ruperto, Amita Aggarwal
Annals of the Rheumatic Diseases. 2025-02-14 - Population-Based Validation Results From the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) Study.Rishi J Desai, Vijay R Varma, Mufaddal Mahesri, Su Been Lee, Ariel Freedman
Clinical Pharmacology and Therapeutics. 2025-02-11
Press Mentions
- A Reason to Mask Sick Kids? Rutgers Study Cites Asthma Declines During PandemicApril 4th, 2023
- Merck's COVID Pill Shows 'Modest' Benefit in High-Risk OutpatientsDecember 16th, 2021
- Health Care Workers Have a Higher Prevalence of COVID-19 Than Non-Health Care WorkersNovember 16th, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: